CVS Health Corporation
Last updated September 27, 2026
Organization details
- Legal name
- CVS Health Corporation
- Former names
- CVS Caremark Corp CVS Corp Melville Corp
- Ownership
- Public
- Status
- Active
- SIC code
- 5912 — Retail-Drug Stores and Proprietary Stores
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Woonsocket
- Headquarters state / province
- Rhode Island
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CVS
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000064803
- EIN
- 05-0494040
Board of directors
-
Alecia A. Decoudreaux · DirectorSince 2023
-
Anne A. Finucane · DirectorSince 2023
-
C. David Brown II · DirectorSince 2023
-
Douglas H. Shulman · DirectorSince 2024
-
Edward J. Ludwig · DirectorSince 2023
-
Fernando Aguirre · DirectorSince 2023
-
Guy P. Sansone · DirectorSince 2024
-
J. David Joyner · Director · President, CEO and ChairSince 2024
-
J. Scott Kirby · DirectorSince 2023
-
Jean Pierre Millon · DirectorSince 2023
-
Jeffrey R. Balser · DirectorSince 2023
-
John E. Gallina · DirectorSince 2026
-
Karen S. Lynch · Director · President and CEOSince 2023
-
Larry Robbins · DirectorSince 2024
-
Leslie Norwalk V · DirectorSince 2024
-
Mary L. Schapiro · DirectorSince 2023
-
Michael F. Mahoney · DirectorSince 2023
-
Nancy Ann Deparle · DirectorSince 2023
-
Roger N. Farah · DirectorSince 2023
Chief executives
J. David Joyner
· President and CEO
Dates unknown
Karen S. Lynch
· President and CEO
Dates unknown
Director election results
Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.7%
-
92.9%
-
93.6%
-
96.0%
-
96.0%
-
96.0%
-
97.4%
-
98.4%
-
98.5%
-
98.6%
-
98.8%
-
98.9%
-
99.1%
Board connections
14 of this board's directors also sit on 19 other boards.
- via Edward J. Ludwig and Michael F. Mahoney
- via John E. Gallina
- via Leslie Norwalk V
- via Karen S. Lynch
- via Michael F. Mahoney
- via Guy P. Sansone
- via Larry Robbins
- via Leslie Norwalk V
- via Nancy Ann Deparle
- via Mary L. Schapiro
- via Leslie Norwalk V
- via Douglas H. Shulman
- via Guy P. Sansone
- via Fernando Aguirre
- via Roger N. Farah
- via Karen S. Lynch
- via J. Scott Kirby
- via Roger N. Farah
- via Anne A. Finucane
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $323,709,755
- 8 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2026 | Clark James David Officer (SVP, Cont & Chief Acct Officer) | Shares withheld for tax | −454 | $90.98 | $41,305 |
| May 31, 2026 | Brian Newman Officer (EVP, Chief Financial Officer) | Shares withheld for tax | −2,478 | $90.98 | $225,448 |
| May 31, 2026 | Compton-Phillips Amy Officer (EVP, Chief Medical Officer) | Shares withheld for tax | −7,618 | $90.98 | $693,086 |
| May 21, 2026 | Fernando Aguirre Director | Sold back to the company | −1,563 | $93.50 | $146,141 |
| May 21, 2026 | Larry Robbins Director | Open-market sale | −370,462 | $93.45 | $34,619,674 |
| May 20, 2026 | Fernando Aguirre Director | Sold back to the company | −30,437 | $93.78 | $2,854,382 |
| May 20, 2026 | Larry Robbins Director | Open-market sale | −797,628 | $93.48 | $74,562,265 |
| May 20, 2026 | Larry Robbins Director | Open-market sale | −152,691 | $94.81 | $14,476,634 |
| May 20, 2026 | Larry Robbins Director | Open-market sale | −66,881 | $95.67 | $6,398,505 |
| May 20, 2026 | Larry Robbins Director | Open-market sale | −800 | $96.28 | $77,024 |
| May 19, 2026 | Larry Robbins Director | Open-market sale | −1,983,387 | $94.45 | $187,330,902 |
| May 19, 2026 | Larry Robbins Director | Open-market sale | −151 | $95.18 | $14,372 |
| May 14, 2026 | Fernando Aguirre Director | Grant or award | +1,563 | $97.15 | $151,845 |
| May 14, 2026 | Jeffrey R. Balser Director | Grant or award | +2,058 | $97.15 | $199,935 |
| May 14, 2026 | J. Scott Kirby Director | Grant or award | +1,447 | $97.15 | $140,576 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.